This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (133)  • Contact me when this article is cited  Related Content  • Related letters  • Related article  • Similar articles in JAMA  Topic Collections  • Psychiatry  • Alert me on articles by topic  Social Bookmarking   What's this?

Frederick K. Goodwin, MD; Bruce Fireman, MA; Gregory E. Simon, MD; Enid M. Hunkeler, MA; Janelle Lee, MHA, DrPH; Dennis Revicki, PhD

JAMA. 2003;290:1467-1473.

Context  Several studies have suggested that lithium treatment reduces risk of suicide in bipolar disorder, but no research has examined suicide risk during treatment with divalproex, the most commonly prescribed mood-stabilizing drug in the United States.

Objective  To compare risk of suicide attempt and suicide death during treatment with lithium with that during treatment with divalproex.

Design and Setting  Retrospective cohort study conducted at 2 large integrated health plans in California and Washington.

Patients  Population-based sample of 20 638 health plan members aged 14 years or older who had at least 1 outpatient diagnosis of bipolar disorder and at least 1 filled prescription for lithium, divalproex, or carbamazepine between January 1, 1994, and December 31, 2001. Follow-up for each individual began with first qualifying prescription and ended with death, disenrollment from the health plan, or end of the study period.

Main Outcome Measures  Suicide attempt, recorded as a hospital discharge diagnosis or an emergency department diagnosis; suicide death, recorded on death certificate.

Results  In both health plans, unadjusted rates were greater during treatment with divalproex than during treatment with lithium for emergency department suicide attempt (31.3 vs 10.8 per 1000 person-years; P<.001), suicide attempt resulting in hospitalization (10.5 vs 4.2 per 1000 person-years; P<.001), and suicide death (1.7 vs 0.7 per 1000 person-years; P = .04). After adjustment for age, sex, health plan, year of diagnosis, comorbid medical and psychiatric conditions, and concomitant use of other psychotropic drugs, risk of suicide death was 2.7 times higher (95% confidence interval [CI], 1.1-6.3; P = .03) during treatment with divalproex than during treatment with lithium. Corresponding hazard ratios for nonfatal attempts were 1.7 (95% CI, 1.2-2.3; P = .002) for attempts resulting in hospitalization and 1.8 (95% CI, 1.4-2.2; P<.001) for attempts diagnosed in the emergency department.

Conclusion  Among patients treated for bipolar disorder, risk of suicide attempt and suicide death is lower during treatment with lithium than during treatment with divalproex.

Author Affiliations: Department of Psychiatry, George Washington University Medical Center, Washington, DC (Dr Goodwin); Best Practice LLC (Dr Goodwin) and Center for Health Outcomes Research, MEDTAP International (Dr Revicki), Bethesda, Md; Division of Research, Kaiser Permanente Medical Care Program, Oakland, Calif (Mr Fireman, Ms Hunkeler, and Dr Lee); Center for Health Studies, Group Health Cooperative, Seattle, Wash (Dr Simon).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTERS

Pharmacotherapy and Risk of Suicidal Behaviors Among Patients With Bipolar Disorder
Charles Bowden and Jan Fawcett
JAMA. 2004;291(8):939.
EXTRACT | FULL TEXT  

Pharmacotherapy and Risk of Suicidal Behaviors Among Patients With Bipolar Disorder
Boghos I. Yerevanian, Ralph J. Koek, and Jamie D. Feusner
JAMA. 2004;291(8):939.
EXTRACT | FULL TEXT  

Pharmacotherapy and Risk of Suicidal Behaviors Among Patients With Bipolar Disorder—Reply
Frederick K. Goodwin, Greg Simon, Dennis Revicki, Enid Hunkeler, Bruce Fireman, and Janelle Lee
JAMA. 2004;291(8):940.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Suicide Risk and Treatments for Patients With Bipolar Disorder
Ross J. Baldessarini and Leonardo Tondo
JAMA. 2003;290(11):1517-1519.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Improving Treatment Adherence in Bipolar Disorder: A Review of Current Psychosocial Treatment Efficacy and Recommendations for Future Treatment Development
Gaudiano et al.
Behav Modif 2008;32:267-301.
ABSTRACT  

Valproic acid interferes with antiviral treatment in human cytomegalovirus-infected endothelial cells
Michaelis et al.
Cardiovasc Res 2008;77:544-550.
ABSTRACT | FULL TEXT  

Reference List for FOCUS Self-Assessment Examination
APPI Online CME 2007;2007:2-2.
FULL TEXT  

Bibliography BIPOLAR DISORDER
Focus 2007;5:40-43.
FULL TEXT  

The Relationship Between Antidepressant Prescription Rates and Rate of Early Adolescent Suicide
Gibbons et al.
Am. J. Psychiatry 2006;163:1898-1904.
ABSTRACT | FULL TEXT  

Suicidal Ideation and Pharmacotherapy Among STEP-BD Patients
Goldberg et al.
Focus 2006;4:565.
FULL TEXT  

Substance use and a history of psychosis are risk factors for serious adverse events in people with bipolar disorder.
Revicki
Evid. Based Ment. Health 2006;9:83-83.
FULL TEXT  

Psychosocial Functioning of Medicaid Recipients With Major Depression
Marcus and Olfson
Psychiatr. Serv. 2006;57:1046-1047.
FULL TEXT  

Old drug, new data: REVISITING... LITHIUM THERAPY
Ferrier et al.
Adv. Psychiatr. Treat. 2006;12:256-264.
ABSTRACT | FULL TEXT  

Suicidal risk in antidepressant drug trials.
Baldessarini et al.
Arch Gen Psychiatry 2006;63:246-248.
FULL TEXT  

Current management of bipolar affective disorder: Is it reflective of the BAP guidelines?
Farrelly et al.
J Psychopharmacol 2006;20:128-131.
ABSTRACT  

Suicidal Ideation and Pharmacotherapy Among STEP-BD Patients
Goldberg et al.
Psychiatr. Serv. 2005;56:1534-1540.
ABSTRACT | FULL TEXT  

Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder
Chisholm et al.
Br. J. Psychiatry 2005;187:559-567.
ABSTRACT | FULL TEXT  

Bipolar Depression in a Low-Income Primary Care Clinic
Olfson et al.
Am. J. Psychiatry 2005;162:2146-2151.
ABSTRACT | FULL TEXT  

Lithium in the Prevention of Suicidal Behavior and All-Cause Mortality in Patients With Mood Disorders: A Systematic Review of Randomized Trials
Cipriani et al.
Am. J. Psychiatry 2005;162:1805-1819.
ABSTRACT | FULL TEXT  

Increased Replication of Human Cytomegalovirus in Retinal Pigment Epithelial Cells by Valproic Acid Depends on Histone Deacetylase Inhibition
Michaelis et al.
IOVS 2005;46:3451-3457.
ABSTRACT | FULL TEXT  

Suicide Risk in Patients Treated With Lithium
Kessing et al.
Arch Gen Psychiatry 2005;62:860-866.
ABSTRACT | FULL TEXT  

Is Your Depressed Patient Bipolar?
Kaye
J Am Board Fam Med 2005;18:271-281.
ABSTRACT | FULL TEXT  

Effects of Valproic Acid Derivatives on Inositol Trisphosphate Depletion, Teratogenicity, Glycogen Synthase Kinase-3{beta} Inhibition, and Viral Replication: A Screening Approach for New Bipolar Disorder Drugs Derived from the Valproic Acid Core Structure
Eickholt et al.
Mol. Pharmacol. 2005;67:1426-1433.
ABSTRACT | FULL TEXT  

Suicide Risk in Placebo-Controlled Trials of Treatment for Acute Manic Episode and Prevention of Manic-Depressive Episode
Storosum et al.
Am. J. Psychiatry 2005;162:799-802.
ABSTRACT | FULL TEXT  

Screening for Bipolar Disorder in a Primary Care Practice
Das et al.
JAMA 2005;293:956-963.
ABSTRACT | FULL TEXT  

The Relationship Between Antidepressant Medication Use and Rate of Suicide
Gibbons et al.
Arch Gen Psychiatry 2005;62:165-172.
ABSTRACT | FULL TEXT  

Advancing the pharmacological treatment of bipolar depression
Frangou
Adv. Psychiatr. Treat. 2005;11:28-37.
ABSTRACT | FULL TEXT  

Lithium Monitoring by Reverse Iontophoresis in Vivo
Leboulanger et al.
Clin. Chem. 2004;50:2091-2100.
ABSTRACT | FULL TEXT  

MOLECULAR EFFECTS of lithium
Quiroz et al.
Mol. Interv. 2004;4:259-272.
ABSTRACT | FULL TEXT  

Bipolar Disorder
Belmaker
NEJM 2004;351:476-486.
FULL TEXT  

Perspectives on Neuroscience and Behavior
Neuroscientist 2004;10:91-92.
 

Use of lithium and the risk of injurious motor vehicle crash in elderly adults: case-control study nested within a cohort
Etminan et al.
BMJ 2004;328:558-559.
FULL TEXT  

Pharmacotherapy and Risk of Suicidal Behaviors Among Patients With Bipolar Disorder
Bowden and Fawcett
JAMA 2004;291:939-939.
FULL TEXT  

Pharmacotherapy and Risk of Suicidal Behaviors Among Patients With Bipolar Disorder
Yerevanian et al.
JAMA 2004;291:939-939.
FULL TEXT  

Risk of suicide in bipolar disorder is least with lithium
BMJ 2004;328:0-0.
FULL TEXT  

What Is a "Mood Stabilizer"? An Evidence-Based Response
Bauer and Mitchner
Am. J. Psychiatry 2004;161:3-18.
ABSTRACT | FULL TEXT  

Lithium Better Than Divalproex In Keeping Suicides Down
Rosack
Psychiatr. News 2003;38:37-47.
FULL TEXT  

Suicide Risk Is Lower with Lithium than with Divalproex in Bipolar Patients
JWatch Psychiatry 2003;2003:3-3.
FULL TEXT  

Suicide Risk and Treatments for Patients With Bipolar Disorder
Baldessarini and Tondo
JAMA 2003;290:1517-1519.
FULL TEXT